PARATEK PHARMACEUTICALS INC - COM (PRTK)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM
Total 13F shares
23,270,933
Share change
+532,954
Total reported value
$59,803,633
Price per share
$2.57
Number of holders
69
Value change
+$2,305,057
Number of buys
28
Number of sells
31

Institutional Holders of PARATEK PHARMACEUTICALS INC - COM (PRTK) as of Q3 2022

As of 30 Sep 2022, PARATEK PHARMACEUTICALS INC - COM (PRTK) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,270,933 shares. The largest 10 holders included AIGH Capital Management LLC, VANGUARD GROUP INC, Omega Fund Management, LLC, GENERAL AMERICAN INVESTORS CO INC, Rock Springs Capital Management LP, Bruce & Co., Inc., BlackRock Inc., Abingworth LLP, Worth Venture Partners, LLC, and 1492 Capital Management LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.